Home
/ PegBio
/ Competitors

PegBio Competitors and Similar CompaniesClear all

Opko Health's competitors and similar companies include IntegraGen, Zytomed Systems and Clinomics.

	Opko Health Opko Health engages in the discovery and development of novel and proprietary technologies for pharmaceuticals and diagnostics.	IntegraGen IntegraGen is a biotechnology company developing molecular markers for central nervous system and metabolic diseases.	Zytomed Systems Zytomed Systems is a company specializing in pathology diagnostics.	Clinomics Clinomics (주식회사 클리노믹스) is a biotechnology company that provides genome-based cancer and disease diagnostic solutions.
Founding Date	Founding Date 2007	Founding Date 2000	Founding Date 2005	Founding Date 2011
Type	Type Public	Type Public	Type Private	Type Public
Tags	Tags Healthcare biotech medical diagnostics pharma	Tags Healthcare biotech medical diagnostics pharma	Tags Healthcare biotech medical diagnostics pharma	Tags Healthcare biotech medical diagnostics pharma
Locations	Locations Miami, US HQ Woburn, US	Locations Évry, FR HQ Cambridge, US	Locations Berlin, DE HQ	Locations HQ
Employees	Employees 6,0967% increase	Employees 4420% decrease	Employees 353% decrease	Employees N/A
Valuation ($)	Valuation ($) 1.1 b	Valuation ($) 3.8 m	Valuation ($) N/A	Valuation ($) N/A
Financial
Revenue (est.)	Revenue (est.) $606.9m (FY, 2025)	Revenue (est.) €5m (FY, 2025)	Revenue (est.) N/A	Revenue (est.) ₩8.5b (FY, 2024)
Cost of goods	Cost of goods $400.9m (FY, 2025)	Cost of goods €1.8m (FY, 2025)	Cost of goods N/A	Cost of goods ₩7.7b (FY, 2024)
Gross profit	Gross profit $205.9m (FY, 2025)	Gross profit €3.4m (FY, 2025)	Gross profit N/A	Gross profit ₩2b (FY, 2024)
Net income	Net income ($225.7m) (FY, 2025)	Net income (€2.7m) (FY, 2025)	Net income N/A	Net income (₩47.1b) (FY, 2024)
Funding
Total funding raised	Total funding raised $ 31m	Total funding raised $ 14.3m	Total funding raised N/A	Total funding raised N/A